Document is current
Any future updates will be listed below
-
Authors
Hadji, Peyman
Hardtstock, Fränce
Wilke, Thomas
Joeres, Lars
Toth, Emese
Möckel, Luis https://orcid.org/0000-0002-1338-8433
Gille, Patrick
- License Information
-
More Information
Article History
Received: 5 December 2019
Accepted: 29 July 2020
First Online: 12 August 2020
Compliance with ethical standards
: The study protocol was reviewed by a scientific steering committee to which all the authors as well as the data provider, AOK PLUS, belonged. The study was performed in line with acknowledged guidelines for observational studies (Good Pharmacoepidemiologic Practice [GPP], Good Practice of Secondary Data Analysis [GPS]).
: PH: Received research funding, consultancy, and lecture fees from Amgen Inc., AstraZeneca, Eli Lilly, Gedeon Richter, Mylan, Novartis, Pfizer, and UCB Pharma. FH: Employee of IPAM; paid consultant for this study. TW: Employee of Ingress Health GmBH; paid consultant for this study. LJ, ET, PG: UCB Pharma employees. LM: Former UCB Pharma employee; received consultancy and lecture fees from UCB Pharma.
